Myriad Genetics (MYGN) Stock Insights

MYGN price $6.63 +0.34 +5.48%

Ticker
MYGN
Price
$6.63
Change
+0.34 +5.48%
Market cap ?
$634.64M
P/E ?
-5.26
Dividend yield ?
0.00%
Beta ?
1.64
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Stocklytics score
34
Value
58
Quality
37
Growth
8

Stocklytics score rationale: value 58, quality 37, growth 8.

Financials

2016201720182019202020212022202320242025
728700000743700000851100000638600000557000000690600000678400000753200000837600000824500000

Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women’s health, and pharmacogenomics. It also provides MyRisk Hereditary Cancer test, a DNA sequencing test for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic test, a DNA sequencing test for metastatic breast, ovarian, metastatic…

Fair value

MYGN fair value $6.00. Price $6.63. Price is 11% above fair value.

Above fair value, but less expensive than usual. A smaller premium than on 66% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 113.26M. Growth 0.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 12.00% (beta 1.6). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 95.65M. Net debt 60.20M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the median P/E of the company's industry. That median uses listed stocks worth at least $10 billion with a positive P/E of 100 or below, and the industry needs at least eight of them. Otherwise the sector median is used when that group also has at least eight, then the market median of those large companies. The multiple used is the lower of that median and 1.25 times the stock's own 10-year median P/E, then kept between 8 and 30. If the stock has no 10-year median, the peer median is kept between 8 and 30. Fair value is the average of the cash-flow value and the earnings value when both exist. Card and credit companies use the earnings value only, because changes in customer receivables distort free cash flow. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Compare MYGN

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-04—-0.17—191.33M
2026-07-30-0.25-0.06190.70M206.03M
2026-05-05-0.09-0.06200.40M202.42M
2026-02-230.04-0.02209.80M207.44M
2025-11-03-0.13-0.01205.70M206.96M
2025-08-050.05-0.01213.10M205.24M
2025-05-06-0.03-0.05195.90M211.71M
2025-02-240.030.03210.60M210.35M
2024-11-070.060.02213.30M213.56M
2024-08-060.050.01211.50M204.95M
2024-05-07-0.01-0.11202.20M193.51M
2024-02-270.040.01196.60M194.78M
2023-11-06-0.03-0.08191.90M194.03M
2023-08-03-0.08-0.10183.50M187.13M
2023-05-03-0.21-0.19181.20M171.55M
2023-02-28-0.12-0.16177.80M169.47M
2022-11-01-0.19-0.06156.40M170.07M
2022-08-040.040.01179.30M170.96M
2022-05-05-0.03-0.05164.90M156.67M
2022-02-24-0.02-0.02160.80M162.96M
2021-11-02-0.020.01167.30M166.30M
2021-08-030.12-0.07189.40M165.11M
2021-05-03-0.06-0.14173.10M156.20M
2021-02-23-0.12-0.12154.60M150.39M
2020-11-09-0.15-0.33145.20M196.02M
2020-08-13-0.31-0.3693.20M141.30M
2020-05-05-0.08-0.01164.00M20.50M
2020-02-060.230.31195.10M246.00M
2019-11-040.080.33186.30M745.20M
2019-08-130.410.47215.40M246.92M
2019-05-070.460.44216.60M197.77M
2019-02-050.380.41216.80M222.51M
2018-11-060.430.30202.30M141.14M
2018-08-210.380.33200.90M169.26M
2018-05-080.310.27193.50M168.53M
2018-02-060.310.24194.00M150.19M
2017-11-070.260.21190.20M153.62M
2017-08-080.300.26200.50M173.77M
2017-05-020.270.24196.90M167.73M
2017-02-070.260.24196.50M181.38M

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency Monthly.

Safety score 43/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. Dividend history is short. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
2009-07-01$1.75——Monthly
2009-06-15$1.75——Monthly

Insider trades

DateInsiderActionSharesPriceValue
2026-09-21Wheeler Benjamin RichardSell2.56K$4.0110.25K
2026-09-16Donnelly Brian JOther0——
2026-09-16Sikri VishalBuy257.73K——
2026-09-16Sikri VishalOther0——
2026-09-03Fox Jennifer LynneSell4.40K$3.2314.21K
2026-08-16Wheeler Benjamin RichardSell8.76K$3.0326.55K
2026-06-23Skovronsky DanielOther0——
2026-06-11Raha Samraat S.Buy3.54K$3.9413.94K
2026-06-11Donnelly Brian JBuy5.00K$3.9419.68K
2026-06-08Kumar RashmiSell15.00K$4.4666.84K
2026-06-04Skovronsky DanielBuy59.70K——
2026-06-04Newcomer Lee NisleyBuy59.70K——
2026-06-04Davis Mark StevenBuy59.70K——
2026-06-04Phanstiel S. LouiseBuy59.70K——
2026-06-04Dreismann HeinrichBuy59.70K——
2026-06-04Reitan Colleen FBuy59.70K——
2026-06-04Bisaro PaulBuy59.70K——
2026-06-04Kumar RashmiBuy59.70K——
2026-06-01Jampa RajBuy251.89K——
2026-06-01Jampa RajOther0——
2026-05-14Bisaro PaulBuy7.50K$3.6927.64K
2026-05-01Donnelly Brian JSell55.98K$4.80268.68K
2026-04-14Verratti MarkSell1.07K$4.915.25K
2026-04-14Muzzey DaleSell946$4.914.64K
2026-03-22Muzzey DaleSell2.02K$4.589.25K
2026-03-22Verratti MarkSell2.06K$4.589.41K
2026-03-22Wheeler Benjamin RichardSell549$4.582.51K
2026-03-15Haas Kevin RichardSell3.35K$4.6615.63K
2026-03-15Haas Kevin RichardSell8.38K$4.6639.06K
2026-03-15Muzzey DaleSell4.78K$4.6622.29K
2026-03-15Muzzey DaleSell11.95K$4.6655.68K
2026-03-15Verratti MarkSell5.61K$4.6626.15K
2026-03-15Verratti MarkSell9.10K$4.6642.39K
2026-03-15Wheeler Benjamin RichardSell877$4.664.09K
2026-03-15Wheeler Benjamin RichardSell2.19K$4.6610.21K
2026-03-14Haas Kevin RichardSell4.16K$4.6619.39K
2026-03-14Solaiman ShereenSell5.78K$4.6626.95K
2026-03-14Muzzey DaleSell8.29K$4.6638.62K
2026-03-14Verratti MarkSell5.42K$4.6625.25K
2026-03-14Wheeler Benjamin RichardSell1.10K$4.665.11K
2026-03-14Raha Samraat S.Sell10.82K$4.6650.40K
2026-03-13Haas Kevin RichardSell6.41K$4.6629.88K
2026-03-13Solaiman ShereenSell8.90K$4.6641.47K
2026-03-13Muzzey DaleSell12.78K$4.6659.55K
2026-03-13Fox Jennifer LynneSell6.00K$4.6627.94K
2026-03-13Verratti MarkSell9.16K$4.6642.70K
2026-03-13Wheeler Benjamin RichardSell586$4.662.73K
2026-03-13Raha Samraat S.Sell36.30K$4.66169.18K
2026-03-12Solaiman ShereenBuy173.20K——
2026-03-12Muzzey DaleBuy173.20K——
2026-03-12Fox Jennifer LynneBuy195.88K——
2026-03-12Donnelly Brian JBuy226.80K——
2026-03-12Verratti MarkBuy247.42K——
2026-03-12Wheeler Benjamin RichardBuy206.19K——
2026-03-12Raha Samraat S.Buy618.56K——
2026-03-09Raha Samraat S.Buy40.00K$5.00199.84K
2026-03-01Solaiman ShereenSell1.68K$4.617.72K
2026-02-27Phanstiel S. LouiseBuy48.00K$4.66223.73K
2026-02-26Phanstiel S. LouiseBuy50.41K$4.80242.10K
2026-02-25Phanstiel S. LouiseBuy6.10K$4.7428.89K
2026-02-02Wheeler Benjamin RichardBuy4.99K——
2026-02-02Verratti MarkBuy32.81K——
2026-02-02Muzzey DaleBuy23.70K——
2026-02-02Haas Kevin RichardBuy23.70K——
2026-01-01Muzzey DaleSell418$6.152.57K
2025-12-25Wheeler Benjamin RichardSell21$6.55138
2025-12-11Raha Samraat S.Sell29.63K$7.30216.33K
2025-11-03Ancona MargaretOther0——
2025-10-24Munk NatalieOther0——
2025-09-21Verratti MarkSell1.08K$7.778.43K
2025-09-21Munk NatalieSell962$7.777.47K
2025-09-21Wheeler Benjamin RichardSell2.56K$7.7719.88K
2025-09-21Ancona MargaretSell958$7.777.44K
2025-09-03Fox Jennifer LynneSell4.43K$6.8030.16K
2025-08-18Leffler Scott J.Other0——
2025-08-16Wheeler Benjamin RichardBuy60.00K——
2025-08-16Wheeler Benjamin RichardOther0——
2025-06-05Dreismann HeinrichBuy49.80K——
2025-06-05Bisaro PaulBuy49.80K——
2025-06-05Davis Mark StevenBuy24.15K——
2025-06-05Phanstiel S. LouiseBuy49.80K——
2025-06-05Newcomer Lee NisleyBuy49.80K——
2025-06-05Reitan Colleen FBuy49.80K——
2025-06-05Kumar RashmiBuy49.80K——
2025-06-05Skovronsky DanielBuy49.80K——
2025-05-31Raha Samraat S.Buy1.50K$3.565.34K
2025-05-01Donnelly Brian JBuy127.63K——
2025-05-01Donnelly Brian JBuy269.90K——
2025-05-01Donnelly Brian JBuy236.17K——
2025-05-01Donnelly Brian JOther0——
2025-04-30Verratti MarkBuy105.78K——
2025-04-30Raha Samraat S.Buy141.05K——
2025-04-30DIAZ PAUL JOther0——
2025-04-14Muzzey DaleSell942$8.087.61K
2025-04-14Verratti MarkSell1.08K$8.088.77K
2025-03-25Munk NatalieSell362$9.733.52K
2025-03-24Munk NatalieSell393$9.983.92K
2025-03-24Munk NatalieSell589$9.985.88K
2025-03-24Haas Kevin RichardSell1.18K$9.9811.75K
2025-03-24Haas Kevin RichardSell1.72K$9.9817.21K

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 201, holders -4 vs prior quarter. Ownership 95.78%.

HolderSharesChangeChange %Value
BLACKROCK, INC.10.89M2.00M+22.51%62.18M
MILLENNIUM MANAGEMENT LLC6.62M-48.45K-0.73%37.80M
VESTAL POINT CAPITAL, LP5.74M4.09M+248.00%32.75M
STATE STREET CORP4.99M561.03K+12.68%28.46M
D. E. SHAW & CO., INC.4.58M82.36K+1.83%26.16M
VANGUARD CAPITAL MANAGEMENT LLC4.08M156.85K+4.00%23.30M
ACADIAN ASSET MANAGEMENT LLC3.13M818.38K+35.45%17.84M
VANGUARD PORTFOLIO MANAGEMENT LLC3.08M497.44K+19.26%17.58M
AQR CAPITAL MANAGEMENT LLC2.77M854.39K+44.68%15.80M
MORGAN STANLEY2.48M-687.64K-21.70%14.17M
GEODE CAPITAL MANAGEMENT, LLC2.42M96.82K+4.17%13.80M
GOLDMAN SACHS GROUP INC2.06M-309.25K-13.07%11.74M
JACOBS LEVY EQUITY MANAGEMENT, INC1.89M-196.97K-9.43%10.80M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.1.74M1.74MNew9.94M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.74M-60.68K-3.37%9.94M
QUBE RESEARCH & TECHNOLOGIES LTD1.67M-24.63K-1.46%9.51M
FEDERATED HERMES, INC.1.57M-405.85K-20.54%8.97M
TWO SIGMA INVESTMENTS, LP1.56M273.68K+21.31%8.89M
NUVEEN, LLC1.55M626.59K+68.18%8.83M
MACKENZIE FINANCIAL CORP1.54M1.54MNew8.77M
CITADEL ADVISORS LLC1.53M1.08M+238.53%8.76M
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.1.41M89.20K+6.76%8.04M
ABERDEEN GROUP PLC1.31M198.53K+17.88%7.47M
MARSHALL WACE, LLP1.22M119.05K+10.79%6.98M
DIMENSIONAL FUND ADVISORS LP1.05M312.94K+42.34%6.01M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Myriad Genetics (MYGN) Stock Insights

MYGN$6.63+0.34 +5.48%

$634.64M

Market Cap

-5.26

P/E

—

Forward P/E

34

Score

Price History